Tiago G. De Oliveira

Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer.

Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer.

Journal: Cell reports
Published: April 27, 2026

Spatially-resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma.

Spatially-resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma.

Journal: Molecular cancer
Published: November 10, 2025

Natives Against Invaders: Shared Use of Space and Temporal Segregation of Clouded Tiger-Cats (Leopardus pardinoides) and Domestic Dogs (Canis familiaris) in an Isolated Protected Area.

Natives Against Invaders: Shared Use of Space and Temporal Segregation of Clouded Tiger-Cats (Leopardus pardinoides) and Domestic Dogs (Canis familiaris) in an Isolated Protected Area.

Journal: Ecology and evolution
Published: July 21, 2025

Integrated real-time imaging of executioner caspase dynamics, apoptosis-induced proliferation, and immunogenic cell death using a stable fluorescent reporter platform.

Integrated real-time imaging of executioner caspase dynamics, apoptosis-induced proliferation, and immunogenic cell death using a stable fluorescent reporter platform.

Journal: Cell death discovery
Published: May 12, 2025

Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC.

Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC.

Journal: Nature
Published: April 03, 2025

Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.

Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.

Journal: Cell death and differentiation
Published: September 04, 2024

Model systems to study tumor-microbiome interactions in early-onset colorectal cancer.

Model systems to study tumor-microbiome interactions in early-onset colorectal cancer.

Journal: EMBO molecular medicine
Published: August 30, 2024

High-Load Core@Shell Nanocarriers with Irinotecan and 5-Fluorouracil for Combination Chemotherapy in Colorectal Cancer.

High-Load Core@Shell Nanocarriers with Irinotecan and 5-Fluorouracil for Combination Chemotherapy in Colorectal Cancer.

Journal: Small science
Published: April 30, 2024

Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.

Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.

Journal: bioRxiv : the preprint server for biology
Published: March 11, 2024

High CIB1 expression in colorectal cancer liver metastases correlates with worse survival and the replacement histopathological growth pattern.

High CIB1 expression in colorectal cancer liver metastases correlates with worse survival and the replacement histopathological growth pattern.

Journal: Molecular therapy. Oncology
Published: February 02, 2024

Tumor Vessel Normalization via PFKFB3 Inhibition Alleviates Hypoxia and Increases Tumor Necrosis in Rectal Cancer upon Radiotherapy.

Tumor Vessel Normalization via PFKFB3 Inhibition Alleviates Hypoxia and Increases Tumor Necrosis in Rectal Cancer upon Radiotherapy.

Journal: Cancer research communications
Published: February 02, 2024

KRASG 12C-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening.

KRASG 12C-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening.

Journal: Molecular oncology
Published: November 03, 2023
Showing 1-12 of 27

Last Updated: 09/26/2026